BioCardia, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioCardia, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • BioCardia, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $36.7M, a 8.03% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $36.7M +$2.73M +8.03% Dec 31, 2023 10-K 2024-03-27
Q4 2022 $34M +$2.88M +9.26% Dec 31, 2022 10-K 2024-03-27
Q4 2021 $31.1M +$2.66M +9.37% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $28.4M +$3.33M +13.3% Dec 31, 2020 10-K 2022-03-29
Q4 2019 $25.1M +$3.28M +15% Dec 31, 2019 10-K 2021-03-30
Q4 2018 $21.8M +$3.17M +17% Dec 31, 2018 10-K 2020-04-09
Q4 2017 $18.7M -$2.97M -13.7% Dec 31, 2017 10-K 2019-04-02
Q4 2016 $21.6M +$2.76M +14.6% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $18.9M +$14.2M +303% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $4.69M -$89K -1.86% Dec 31, 2014 10-K 2016-03-25
Q4 2013 $4.78M -$12K -0.25% Dec 31, 2013 10-K 2015-03-24
Q4 2012 $4.79M +$162K +3.5% Dec 31, 2012 10-K 2014-03-24
Q4 2011 $4.63M Dec 31, 2011 10-K 2013-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.